• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.14% Nasdaq Down 0.35%

    CytRx Corporation (CYTR)

    -NasdaqCM
    2.45 Sep 3, 4:00PM EDT
    Add to Portfolio
    Prev Close:2.45
    Open:N/A
    Bid:N/A
    Ask:N/A
    1y Target Est:8.50
    Beta:3.05381
    Earnings Date:Nov 2 - Nov 6 (Est.)
    Day's Range:N/A - N/A
    52wk Range:1.98 - 5.42
    Volume:0
    Avg Vol (3m):823,937
    Market Cap:162.88M
    P/E (ttm):N/A
    EPS (ttm):-0.87
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for CYTR

    Comparison

    Symbol% ChgMkt Cap
    CYTR 0.00%162.88M
    LLY86.41B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):1,628.76
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.99
    Quarterly EPS Est (Sep-15) :-0.24
    Mean Recommendation*:1.5
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    CytRx Corporation operates as a biopharmaceutical research and development company specializing in oncology. The company’s product candidate is aldoxorubicin, which is in Phase III clinical trial as a therapy for patients with soft tissue sar... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback